ITEM
1. BUSINESS.
General
Located
in Jericho, New York, the Company, through its wholly-owned subsidiary, Eco-Logical Concepts Inc., sells its bioremediation products
for the treatment of sewers, sludge ponds, septic tanks, lagoons, farms, car washes, portable sanitation facilities, grease tanks,
lakes and ponds under the brands TRAP-EZE, SEPT-EZE, TANK-EZE and WASH-EZE to distributors who resell the Company’s products
to end user customers.
The
active ingredients in our tablets oxygenate wastewater, remove hydrogen sulfide odors, prevent corrosion in wastewater systems
and initiate aerobic biological breakdown of organic sludge including fats, oils and grease. The tablets are non-toxic to the
environment, non-caustic and comprised of natural ingredients that do not require any special permitting for use and disposal.
The product is simple to use directly by the end consumer.
The
Company has formulated a business model that management believes can help it grow and achieve economies of scale over time. We
have undertaken the necessary due diligence and prepared a business that will enable us to compete in the market for bio-remediation
services.
The
Company is focused on building, acquiring and investing in businesses around ecological and life sciences. From waste water remediation
to healthcare and more, Ecosciences is committed to building a better living environment for all people.
Product
Development
We
have developed a variety of products to serve various market segments:
●
|
Tank-Eze
Wastewater Tablets
. These are solid, sustained release tablets which provide active oxygen, nutrients, buffers and safe
aerobic microorganisms to help clean, control odor and keep wastewater systems running efficiently with reduced downtime.
These tablets can be used in pump and lift stations, septic tank systems and other waste-water treatment systems.
|
|
|
●
|
Trap-Eze
Grease Trap Tablets
. These are solid, sustained release tablets which provide active oxygen, nutrients, buffers and safe
aerobic microorganisms to help clean, deodorize and keep grease traps running efficiently with reduced downtime. These tablets
can be used by a wide variety of food service industry customers.
|
|
|
●
|
Wash-Eze
Car Wash Tablets
. These are solid, sustained release tablets that reduce noxious odors, spotting and other problems associated
with the use of reclaimed (e.g., recycled) water. Environmentally safe, non-toxic, micro-fine components and aerobic and anaerobic
microorganisms, help clean and mitigate odors, while providing nutrients, buffers and active oxygen to increase efficiency
and reduce maintenance.
|
Growth
Strategy of the Company
Our
mission is to maximize stockholder value through expanding the scope of products offered. We intend to conduct research and development
to bring new, improved products to market to ensure we are competitive in our market space. We intend to focus on growing our
distribution channels using master-distributor relationships, full-line distributors and other similar sales channels. We intend
to build product and brand awareness through a direct retail channel using online marketing and info-commercials, which we believe
will provide a feedback benefit for the growth of our other distribution channels as well as to establish opportunities for indirect
retail sales channels, such as through chain stores and small retailers.
We
have been working to set up regional distributors in several different market segments, such as septic systems, grease traps,
ponds, agricultural and wastewater. Sales this fiscal year have primarily been to Mexico, and we are currently finalizing more
orders locally in New Jersey. All sales were completed in US dollars and have not been subject to any foreign taxes.
During
the fiscal year ended May 31, 2016, we commenced developing additional eco-based products in order to expand our product line.
During the quarter ended November 30, 2015, we successfully test marketed a liquid version of our Tank-Eze bioremediation product
(“Liquid Tank-Eze”). Liquid-Eze is different than the regular Tank-Eze in that it does not have the oxygen feature
and is designed to be primarily used in the treatment of drain lines prior to, or in conjunction with, Tank-Eze. As part of its
test marketing, we sold the Liquid Tank-Eze product in a four ounce (4 oz.) concentrated size through our online channels. We
intend to increase our marketing of Liquid Tank-Eze with a wider and more official launch in the near future. We also intend to
sell a line of eco-friendly certified green cleaning solutions, including but not limited to, a multi-surface cleaner and a glass
cleaner.
The
following items are significant agreements entered during the past years to expand our business:
|
●
|
In
July 2015, the Company entered into a Master Distribution Agreement (“MDA”) with Chem-tek Industries, Inc. (“Chem-tek”),
a janitorial supply company based in Howell, New Jersey. The MDA gives Chem-tek the right to resell the Company’s products
in the south New Jersey counties of Atlantic, Bergen, Burlington, Camden, Cape May, Essex, Middlesex, Monmouth, Ocean, Salem
and Somerset for one-year renewable terms.
|
|
|
|
|
●
|
In
August 2015, the Company entered into an exclusive International Master Distributor Agreement with Eco Logic Limited (“Eco
Logic”), its current New Zealand and South African distributor of the Company’s range of products for use in the
biological treatment of wastewater. In the New Zealand market, Eco Logic Limited resells the Company’s products under
the Nova Tabs (www.novatabs.com) brand name. Past purchasers of the Nova Tabs in New Zealand have included McDonalds franchises
as well as governmental body, the Tauranga City Council (www.tauranga.govt.nz). The International Master Distributor Agreement
contractually formalizes the Company and Eco Logic’s business relationship and is intended to increase product distribution
and sales in New Zealand and other territories where Eco Logic has or is seeking customers. The term of the Agreement is for
five years with successive five year terms if not otherwise terminated and the territory includes Africa, Australasia, Germany
and The Netherlands.
|
|
|
|
|
●
|
In
November 2015, the Company announced that it had started preliminary discussions with several potential international distributors
to establish sales channels for the Company’s products and that it was developing sales programs to facilitate sales
to government agencies for the treatment of waste water and grease build up issues. Those discussions with potential international
distributors are still ongoing as of the date of this report.
|
|
|
|
|
●
|
In
February 2016, the Company commenced a focused marketing program targeting specific US-based industries, starting with janitorial
supply companies and then restaurants and hotels. The Company had also previously launched a program to secure distributors
by region. The Company’s marketing program will include, but not be limited to, trade shows, trade associations and
trade magazines. In the future, the Company plans to expand the marketing program to include farming and hospitals and food
processing plants.
|
|
●
|
In
March 2016, the Company entered into a Master Distribution Agreement (“MDA”) with Concepto Ecologicos Aplicados
(“CONEAP”), a janitorial supply company based in Santo Domingo, Dominican Republic. The MDA gives CONEAP the right
to resell the Company’s products for the region of the Dominican Republic for one-year renewable terms.
|
|
|
|
|
●
|
In
March 2016, the Company entered into a Distribution Agreement with Everglades Supply Co, Inc., a maintenance, industrial and
janitorial supply company based in Farmingdale, NY (“Everglades”). The Distribution Agreement gives Everglades
the right to resell the Company’s products in the Northeastern Tri-State area (New York-New Jersey-Connecticut), South
Florida and the Middle East for successive one-year automatically renewable terms.
|
Revenue
Model
We
are in the process of establishing a network of master distributors, full-line distributors and sales representatives to service
a diverse group of end users. Our target markets include municipalities, retail consumers, commercial and industrial users, food
processors, hospitals, supermarkets, restaurants and the janitorial supply industry as follows:
|
a.
|
Sewage
treatment plants
|
|
|
|
|
b.
|
Pump
and Lift Stations
|
|
|
|
|
c.
|
Ponds
and small lakes (golf courses typically have odor and algae issues in their water hazards)
|
2.
|
Commercial
Foods Industry:
Facilities with grease traps including restaurants, supermarkets and other facilities with commercial
kitchens.
|
|
|
3.
|
Hospitals
and Medical Facilities:
Our products are used in the breakdown of organic material such as blood and tissue which typically
clogs hospital drains and causes odor problems.
|
|
|
4.
|
Industrial
Food Processing Plants:
Facilities with grease traps and septic tanks.
|
|
|
5.
|
Retail:
A significant percentage of homes and other facilities throughout the country operate with septic tanks. Our tablets are
designed to treat the waste material that builds up in the tanks and prevent the buildup of methane and sulfuric acid from
compacted solids which leads to the degradation and potential collapse of the septic system.
|
We
intend to target sales for municipalities, the commercial foods industry, hospital and medical facilities and industrial food
processing plants using a network of master distributorships, full-line distributors and other sales representatives who will
work with us on a commission basis. We intend to reach the retail market through info-commercials to build awareness of our products
and brand, internet marketing and eventual placement in chain retail locations and small retailers directly or through distributors
with traditional retailer/wholesaler relationships.
Competitive
Analysis
Our
competition does not come from other tablets as we are unique in the market. However, within this category there are other alternatives.
They include pumping, which is costly, intrusive and has a negative impact on the environment. There are powders and liquids that
contain bacteria. Neither contains any oxygenating elements nor do they resolve issues with accumulated and compacted solid material.
Our tablets embed themselves into the compacted mass and effervesce disturbing the material and infusing oxygen into the area
so aerobic bacteria can go to work. Grease traps, lift stations, septic systems are all designed to allow for the flow of liquid
through the systems. Therefore, powders and liquids will simply flow through the system and not establish bacteria colonies.
The
Company’s primary competitors in the environmental bio-remediation services industry are Spartan Chemical, Zep, and Arrow
Chemical. We consider the competition to be competent, experienced, and they have greater financial and marketing resources than
we do at the present time. Our ability to compete may be adversely affected by the ability of these competitors to devote greater
resources to the marketing of their services than are available to our Company. Some of the Company’s competitors also offer
a wider scope of services and have greater name recognition. Our competitors include large firms that also have extensive existing
customer bases and established distribution channels.
Sources
and Availability of Raw Materials and the Names of Principal Suppliers
We
purchase our raw materials as bulk dry bacterial enzymes from Bio-cat Microbials (“Bio-cat”). We purchase our raw
material by using purchase orders and do not have any contractual relationship with Biocat. Biocat ships the bulk biomaterial
to Mid-Continent Packaging Inc. (“MCP”) who presses and packages the tablets. Large orders of our finished product
are then shipped directly from MCP to our major customers. Smaller orders are shipped to our office.
The
loss of our current principal suppliers would not have a material adverse effect on our Company. Within our industry, there are
a number of manufacturers and pressers, giving us flexibility and options.
Dependence
on One or a Few Major Customers
The
Company, through Eco-Logical Concepts, sells its products to distributors who then resell them to end user customers. The Company
currently does business with up to five distributors in Mexico, the U.S. and New Zealand, one of which accounts for 40% of our
revenues. The loss of this distributor or a group of distributors generating a majority of our revenues could have a material
adverse effect on the Company.
The
Company’s revenues were concentrated among three customers for the year ended May 31, 2017, and four customers for the year
ended May 31, 2016:
Customer
|
|
|
For
the Year Ended
May 31, 2017
|
|
|
For
the Year Ended
May 31, 2016
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
47
|
%
|
|
|
40
|
%
|
|
2
|
|
|
|
14
|
%
|
|
|
20
|
%
|
|
3
|
|
|
|
10
|
%
|
|
|
14
|
%
|
|
4
|
|
|
|
*
|
%
|
|
|
11
|
|
*
not greater than 10%
Patents,
Trademarks, Licenses, Franchises, Concessions, Royalty Agreements or Labor Contracts
We
do not currently own any patents or trademarks nor are we a party to any licenses, franchises, concessions, royalty agreements
or labor contracts.
Need
for any Government Approval of Products or Services
There
are no government regulations for our product or any powder or liquid enzyme products.
Effect
of Existing or Probable Governmental Regulations on the Company
We
will be subject to federal laws and regulations that relate directly or indirectly to our operations, including securities laws.
We will also be subject to common business and tax rules and regulations pertaining to the operation of our business.
Research
and Development Activities
We
have not spent any money on research and development activities during the fiscal years ended May 31, 2017 and 2016.
Costs
and Effect of Compliance with Environmental Laws
Since
there are no government regulations for our product or any powder or liquid enzyme products. We believe there are no applicable
costs or effects of compliance with environmental laws.
Employees
We
have two full-time employees, Joel Falitz, our CEO and director, and Dan Cohen, our COO.
Dividend
Policy
We
have never paid or declared dividends on our securities. The payment of cash dividends, if any, in the future is within the discretion
of our Board and will depend upon our earnings, our capital requirements, financial condition and other relevant factors. We intend,
for the foreseeable future, to retain future earnings for use in our business.
Description
of Properties
Our
principal executive offices are located at 420 Jericho Turnpike, Suite 110, Jericho, NY, 11753. Our telephone number is (516)
465-3964. Our executive offices are currently provided to us for no charge by our President. In the future, as we expand, we expect
to execute a lease agreement with our President or lease other office space. We also maintain a website located at
www.ecosciences.company
,
the contents of which are not incorporated into this report.
Corporate
History
We
were formally known as On-Air Impact, Inc., a Nevada corporation (“On-Air Impact”). From the date of its inception
on May 26, 2010 until the consummation of the reverse merger described below on May 9, 2014, On-Air Impact was a “shell
company” (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)).
On
May 9, 2014, On-Air Impact and its wholly-owned subsidiary, Eco Merger Sub, Inc., a Delaware corporation (“Merger Sub”),
consummated a reverse merger (the “Merger”) with Eco-Logical Concepts, Inc., a Delaware corporation (“Eco-Logical”),
pursuant to the terms and conditions of that certain Agreement and Plan of Merger, dated May 9, 2014 (the “Merger Agreement”),
whereby Merger Sub merged with and into Eco-Logical with Eco-Logical being the surviving corporation and replacing Merger Sub
as On-Air Impact’s wholly-owned subsidiary. Since the Merger, the business and operations of Eco-Logical have been business
and operations of On-Air Impact.
At
the closing of the Merger:
●
|
Every
one hundred (100) shares of common stock, par value $0.0001 per share, of Eco-Logical issued and outstanding immediately prior
to the closing of the Merger was converted into one (1) share of common stock, par value $0.0001 per share (the “Common
Stock”), of On-Air Impact, rounding up to the nearest whole number for resulting fractional shares; and
|
|
|
●
|
Each
share of Series A Non-Convertible Preferred Stock, par value $0.0001 per share, of Eco-Logical issued and outstanding immediately
prior to the closing of the Merger was converted into one share of Series B Non-Convertible Preferred Stock, par value $0.0001
per share (the “Series B Non-Convertible Preferred Stock”), of On-Air Impact.
|
In
addition, pursuant to the Merger Agreement, on May 9, 2014, Joel Falitz, the President and Chief Executive Officer of Eco-Logical,
was appointed to serve as the Chairman of our Board of Directors for a one-year period until the next annual stockholders’
meeting or until his successor is elected and qualified and as the Chief Executive Officer, President, Secretary and Treasurer
of the Company.
As
a result of the Merger, On-Air Impact ceased to be a shell company. The information contained in our “Super Form 8-K”
filed on May 15, 2014 constitutes the current “Form 10 information” necessary to satisfy the conditions contained
in Rule 144(i)(2) under the Securities Act of 1933, as amended (the “Securities Act”).
The
Merger was intended to be treated as a tax-free reorganization under Section 368(a) of the Internal Revenue Code of 1986, as amended,
and has been treated as a recapitalization of the Company for financial accounting purposes. Even though On-Air Impact was the
legal acquirer, Eco-Logical is considered to be the acquirer for accounting purposes, and the Company’s historical financial
statements before the Merger were replaced with the historical financial statements of Eco-Logical before the Merger in this Report
and all future filings with the SEC.
To
better reflect our new operations as a result of the Merger, on June 23, 2014, the Company changed its name from “On-Air
Impact” to “Ecosciences, Inc.” On June 23, 2014, we also increased our authorized capital stock from 100 million
shares of Common Stock to 500 million shares; and from 10 million shares of “blank check” Preferred Stock, par value
$0.0001 per share (“Preferred Stock”) to 50 million shares. We also effectuated a 500-for-1 forward stock split of
our outstanding Common Stock on June 23, 2014 (the “Forward Stock Split”).
Also,
on June 23, 2014, the former directors each resigned as a member of our Board of Directors. Their resignations were not due to
any disagreement with the Company nor were they related to our operations, policies or practices.
On
July 21, 2014, the ticker symbol of our Common Stock on the OTCQB was changed from “OAIR” to “ECEZ” to
better reflect our new name.
ITEM
1A. RISK FACTORS.
AN
INVESTMENT IN OUR SECURITIES IS HIGHLY SPECULATIVE AND INVOLVES A HIGH DEGREE OF RISK. WE FACE A VARIETY OF RISKS THAT MAY AFFECT
OUR OPERATIONS OR FINANCIAL RESULTS AND MANY OF THOSE RISKS ARE DRIVEN BY FACTORS THAT WE CANNOT CONTROL OR PREDICT. BEFORE INVESTING
IN THE SECURITIES YOU SHOULD CAREFULLY CONSIDER THE FOLLOWING RISKS, TOGETHER WITH THE FINANCIAL AND OTHER INFORMATION CONTAINED
IN THIS REPORT. IF ANY OF THE FOLLOWING RISKS ACTUALLY OCCURS, OUR BUSINESS, PROSPECTS, FINANCIAL CONDITION AND RESULTS OF OPERATIONS
COULD BE MATERIALLY ADVERSELY AFFECTED. IN THAT CASE, THE TRADING PRICE OF OUR COMMON STOCK WOULD LIKELY DECLINE AND YOU MAY LOSE
ALL OR A PART OF YOUR INVESTMENT. ONLY THOSE INVESTORS WHO CAN BEAR THE RISK OF LOSS OF THEIR ENTIRE INVESTMENT SHOULD CONSIDER
AN INVESTMENT IN OUR SECURITIES.
This
Report contains certain statements relating to future events or the future financial performance of our Company. Prospective investors
are cautioned that such statements are only predictions and involve risks and uncertainties, and that actual events or results
may differ materially. In evaluating such statements, prospective investors should specifically consider the various factors identified
in this Report, including the matters set forth below, which could cause actual results to differ materially from those indicated
by such forward-looking statements.
If
any of the following or other risks materialize, the Company’s business, financial condition, and results of operations
could be materially adversely affected which, in turn, could adversely impact the value of our securities. In such a case, investors
in our securities could lose all or part of their investment.
Prospective
investors should consider carefully whether an investment in the Company is suitable for them in light of the information contained
in this Report and the financial resources available to them. The risks described below do not purport to be all the risks to
which the Company could be exposed. This section is a summary of certain risks and is not set out in any particular order of priority.
They are the risks that we presently believe are material to the operations of the Company. Additional risks of which we are not
presently aware or which we presently deem immaterial may also impair the Company’s business, financial condition or results
of operations.
Risks
Associated with Our Business
We
have limited cash on hand and there is substantial doubt as to our ability to continue as a going concern.
At
May 31, 2017, we had $3,357 in cash on hand and working capital deficit of $1,739,953 and for the fiscal year ended May
31, 2017, we had $25,860 in revenues. In their reports for the fiscal years ended May 31, 2017 and 2016,
our auditors have expressed that there is substantial doubt as to our ability to continue as a going concern. We have incurred
operating losses since our formation and expect to incur losses and negative operating cash flows for the foreseeable future.
We expect to incur substantial losses for the foreseeable future and may never become profitable. We also expect to continue to
incur significant operating and capital expenditures for the next several years and anticipate that our expenses will increase
substantially in the foreseeable future. We also expect to experience negative cash flow for the foreseeable future as we fund
our operating losses and capital expenditures. As a result, we will need to generate significant revenues in order to achieve
and maintain profitability. We may not be able to generate these revenues or achieve profitability in the future. Our failure
to achieve or maintain profitability could negatively impact the value of our Common Stock.
We
have a limited operating history upon which investors can evaluate our future prospects.
Our
operating subsidiary, Eco-Logical Concepts, was incorporated in the State of Delaware on November 30, 2011. Therefore, we have
limited operating history upon which an evaluation of our business plan or performance and prospects can be made. The business
and prospects of the Company must be considered in the light of the potential problems, delays, uncertainties and complications
encountered in connection with a newly established business. The risks include, but are not limited to, the possibility that we
will not be able to develop functional and scalable products and services, or that although functional and scalable, our products
and services will not be economical to market; that our competitors hold proprietary rights that preclude us from marketing such
products; that our competitors market a superior or equivalent product; that we are not able to upgrade and enhance our technologies
and products to accommodate new features and expanded service offerings; or the failure to receive necessary regulatory clearances
for our products. To successfully introduce and market our products at a profit, we must establish brand name recognition and
competitive advantages for our products. There are no assurances that the Company can successfully address these challenges. If
it is unsuccessful, the Company and its business, financial condition and operating results could be materially and adversely
affected.
Given
the limited operating history, management has little basis on which to forecast future demand for our products from our existing
customer base, much less new customers. The current and future expense levels of the Company are based largely on estimates of
planned operations and future revenues rather than experience. It is difficult to accurately forecast future revenues because
the business of the Company is new and its market has not been developed. If the forecasts for the Company prove incorrect, the
business, operating results and financial condition of the Company will be materially and adversely affected. Moreover, the Company
may be unable to adjust its spending in a timely manner to compensate for any unanticipated reduction in revenue. As a result,
any significant reduction in revenues would immediately and adversely affect the business, financial condition and operating results
of the Company.
Our
success is highly dependent on Joel Falitz, our President and CEO and Dan Cohen, our COO.
In
the early stages of development, the Company’s business will be significantly dependent on the Company’s Management
team. The Company’s success will be particularly dependent upon Joel Falitz, our CEO and director, and Dan Cohen, our COO,
the loss of either or both would have a material adverse effect on the Company.
Three
of our customers accounted for 71% of our revenues in the fiscal year ended May 31, 2017.
For
the fiscal year ended May 31, 2017, three customers accounted for 71% of our revenues, one of which generated 47% of our revenues.
Our inability to achieve more customers and the loss of any one of those customers could adversely affect our revenues and could
materially adversely affect our business.
We
may not be able to compete successfully with current and future competitors.
We
have many potential competitors in the bio-remediation services industry. We will compete, in our current and proposed businesses,
with other companies, most of which have far greater marketing and financial resources and experience than we do. We cannot guarantee
that we will be able to penetrate our intended market and be able to compete profitably, if at all. In addition to established
competitors, there is ease of market entry for other companies that choose to compete with us. Effective competition could result
in price reductions, reduced margins or have other negative implications, any of which could adversely affect our business and
chances for success. Competition is likely to increase significantly as new companies enter the market and current competitors
expand their services. Many of these potential competitors are likely to enjoy substantial competitive advantages, including,
but not limited to, larger staffs, greater name recognition, larger and established customer bases and substantially greater financial,
marketing, technical and other resources. To be competitive, we must respond promptly and effectively to industry dynamics, evolving
standards and competitors’ innovations by continuing to enhance our services and sales and marketing channels. Any pricing
pressures, reduced margins or loss of market share resulting from increased competition, or our failure to compete effectively,
could fatally damage our business and chances for success.
If
we do not continually update our services, they may become obsolete and we may not be able to compete with other companies.
We
cannot assure you that we will be able to keep pace with advances or that our services will not become obsolete. We cannot assure
you that competitors will not develop related or similar services and offer them before we do, or do so more successfully, or
that they will not develop services and products more effective than any that we have or are developing. If that happens, our
business, prospects, results of operations and financial condition will be materially adversely affected.
We
may be required to borrow funds in the future.
If
the Company incurs indebtedness, a portion of its cash flow will have to be dedicated to the payment of principal and interest
on such indebtedness. Typical loan agreements also might contain restrictive covenants, which may impair the Company’s operating
flexibility. Such loan agreements would also provide for default under certain circumstances, such as failure to meet certain
financial covenants. A default under a loan agreement could result in the loan becoming immediately due and payable and, if unpaid,
a judgment in favor of such lender which would be senior to the rights of members of the Company. A judgment creditor would have
the right to foreclose on any of the Company’s assets resulting in a material adverse effect on the Company’s business,
operating results or financial condition.
Failure
to establish or enhance our brand recognition could have a material adverse effect on our business and results of operations.
We
believe we will need to expend significant time, effort and resources to enhance the recognition of our brands. We believe developing
our brand will be important to our sales and marketing efforts. If we fail to establish or enhance the recognition of our brands,
it could have a material adverse effect on our ability to sell our products and adversely affect our business and results of operations.
If we fail to develop a positive public image and reputation, our business with our existing customers could decline and we may
fail to develop additional business, which could adversely affect our results of operations.
Defects
in our products or failures in quality control could impair our ability to sell our products or could result in product liability
claims, litigation and other significant events involving substantial costs.
Detection
of any significant defects in our products or failure in our quality control procedures may result in, among other things, delay
in time-to-market, loss of sales and market acceptance of our products, diversion of development resources, and injury to our
reputation. The costs we may incur in correcting any product defects may be substantial. Additionally, errors, defects or other
performance problems could result in financial or other damages to our customers, which could result in litigation. Product liability
litigation, even if we prevail, would be time consuming and costly to defend, and if we do not prevail, could result in the imposition
of a damages award. We presently maintain product liability insurance; however, it may not be adequate to cover any claims.
We
rely on indirect sales channels to market and sell our bioremediation product. A loss of or deterioration in our relationship
with one or more of our resellers or distributors, or our inability to establish new indirect sales channels to drive growth of
our products could negatively affect our operating results.
We
sell the majority of our bioremediation products to resellers, who in turn sell our products to end users. In some cases, resellers
integrate our products of other manufacturers and sell the combined products to their own customers. The success of these sales
channels is hard to predict, particularly over time, and we have no purchase commitments or long-term orders from them that assure
us of any baseline sales through these channels. Several of our resellers and distributors carry competing product lines that
they may promote over our products, which may negatively impact our sales. A reseller or distributor might not continue to purchase
our products or market them effectively, and each reseller or distributor determines the type and amount of our products that
it will purchase from us and the pricing of the products that it sells to their customers. Establishing new indirect sales channels
globally is an important part of our strategy to drive growth of our revenue.
Our
operating results could be adversely affected by any number of factors including:
|
●
|
A
change in competitive strategy that adversely affects a reseller’s or distributor’s willingness or ability to
distribute our products;
|
|
|
|
|
●
|
Reaching
fewer customers or losing sales due to ineffective efforts of resellers and distributors;
|
|
|
|
|
●
|
Reduced
margins and increased costs associated with channel sales;
|
|
|
|
|
●
|
An
inability to gain traction in developing new indirect sales channels for our branded products;
|
|
|
|
|
●
|
Any
financial difficulties of our resellers, authorized distributors or customers that result in their inability to pay amounts
owed to us;
|
|
|
|
|
●
|
Changes
in requirements or programs that allow our products to be sold by third parties to government customers; or
|
|
|
|
|
●
|
Changes
in product requirements or certification programs that limit our ability for our products to be sold in our established current
markets.
|
We
may enter into exclusive agreements with our distributors who purchase our products on an individual purchase order basis. If
we lose important distributors, or if they reduce their focus on our products or if we are unable to obtain additional distributors,
our business could be negatively affected.
There
can be no assurances of protection for proprietary rights or reliance on trade secrets.
In
certain cases, the Company may rely on trade secrets to protect intellectual property, proprietary technology and processes, which
the Company has acquired, developed or may develop in the future. There can be no assurances that secrecy obligations will be
honored or that others will not independently develop similar or superior products or technology. The protection of intellectual
property and/or proprietary technology through claims of trade secret status has been the subject of increasing claims and litigation
by various companies both in order to protect proprietary rights as well as for competitive reasons even where proprietary claims
are unsubstantiated. The prosecution of proprietary claims or the defense of such claims is costly and uncertain given the uncertainty
and rapid development of the principles of law pertaining to this area. The Company, in common with other firms, may also be subject
to claims by other parties with regard to the use of intellectual property, technology information and data, which may be deemed
proprietary to others.
Our
ability to become profitable and continue as a going concern will be dependent on our ability to attract, employ and retain highly
skilled individuals to serve our clients.
The
nature of our business requires that we employ skilled persons to perform highly skilled and specialized tasks for our Company.
Our failure to retain such personnel could have a material adverse effect on our ability to offer services to clientele, and could
potentially have a negative effect on our business. There is no guarantee that skilled persons will be available and willing to
work for us in the future, nor is there any guarantee that we could afford to retain them if they are available at a future time.
Our
projections and forward-looking information may prove to be incorrect.
Management
has prepared projections regarding the Company’s anticipated financial performance. The Company’s projections are
hypothetical and based upon a presumed financial performance of the Company, the addition of a sophisticated and well-funded marketing
plan, and other factors influencing the business of the Company. The projections are based on Management’s best estimate
of the probable results of operations of the Company, based on present circumstances, and have not been reviewed by the Company’s
independent accountants. These projections are based on several assumptions, set forth therein, which Management believes are
reasonable. Some assumptions upon which the projections are based, however, invariably will not materialize due to the inevitable
occurrence of unanticipated events and circumstances beyond Management’s control. Therefore, actual results of operations
will vary from the projections, and such variances may be material. Assumptions regarding future changes in sales and revenues
are necessarily speculative in nature. In addition, projections do not and cannot take into account such factors as general economic
conditions, unforeseen regulatory changes, the entry into the Company’s market of additional competitors, the terms and
conditions of future capitalization, and other risks inherent to the Company’s business. While Management believes that
the projections accurately reflect possible future results of the Company’s operations, those results cannot be guaranteed.
We
may not be able to manage our growth effectively.
We
must continually implement and improve our products and/or services, operations, operating procedures and quality controls on
a timely basis, as well as expand, train, motivate and manage our work force in order to accommodate anticipated growth and compete
effectively in our market segment. Successful implementation of our strategy also requires that we establish and manage a competent,
dedicated work force and employ additional key employees in corporate management, product development, client service and sales.
We can give no assurance that our personnel, systems, procedures and controls will be adequate to support our existing and future
operations. If we fail to implement and improve these operations, there could be a material, adverse effect on our business, operating
results and financial condition.
If
we make any acquisitions or enter into a merger or similar transaction, our business may be negatively impacted.
We
have no present plans for any specific acquisition. However, in the event that we make acquisitions in the future, we could have
difficulty integrating the acquired companies’ personnel and operations with our own. In addition, the key personnel of
the acquired business may not be willing to work for us. We cannot predict the effect expansion may have on our core business.
Regardless of whether we are successful in making an acquisition, the negotiations could disrupt our ongoing business, distract
our management and employees and increase our expenses. In addition to the risks described above, acquisitions, mergers and other
similar transactions are accompanied by a number of inherent risks, including, without limitation, the following:
●
|
the
difficulty of integrating acquired products, services or operations;
|
|
|
●
|
the
potential disruption of the ongoing businesses and distraction of our Management and the management of acquired companies;
|
|
|
●
|
the
difficulty of incorporating acquired rights or products into our existing business;
|
|
|
●
|
difficulties
in disposing of the excess or idle facilities of an acquired company or business and expenses in maintaining such facilities;
|
|
|
●
|
difficulties
in maintaining uniform standards, controls, procedures and policies;
|
|
|
●
|
the
potential impairment of relationships with employees and customers as a result of any integration of new management personnel;
|
|
|
●
|
the
potential inability or failure to achieve additional sales and enhance our customer base through cross-marketing of the products
to new and existing customers;
|
|
|
●
|
the
effect of any government regulations which relate to the business acquired; and
|
|
|
●
|
potential
unknown liabilities associated with acquired businesses or product lines, or the need to spend significant amounts to retool,
reposition or modify the marketing and sales of acquired products or the defense of any litigation, whether or not successful,
resulting from actions of the acquired company prior to our acquisition.
|
Our
business could be severely impaired if and to the extent that we are unable to succeed in addressing any of these risks or other
problems encountered in connection with these acquisitions, many of which cannot be presently identified, these risks and problems
could disrupt our ongoing business, distract our management and employees, increase our expenses and adversely affect our results
of operations.
There
might be unanticipated obstacles to the execution of our business plan.
The
Company’s business plans may change significantly. The Company’s potential business endeavors are capital intensive.
Management believes that the Company’s chosen activities and strategies are achievable in light of current economic and
legal conditions with the skills, background, and knowledge of the Company’s principals and advisors. Management reserves
the right to make significant modifications to the Company’s stated strategies depending on future events.
We
may engage in transactions that present conflicts of interest.
The
Company’s officers and directors may enter into agreements with the Company from time to time which may not be equivalent
to similar transactions entered into with an independent third party. A conflict of interest arises whenever a person has an interest
on both sides of a transaction. While we believe that it will take prudent steps to ensure that all transactions between the Company
and any officer or director are fair, reasonable, and no more than the amount it would otherwise pay to a third party in an “arms’-length”
transaction, there can be no assurance that any transaction will meet these requirements in every instance.
We
have agreed to indemnify our officers and directors against lawsuits to the fullest extent of the law.
Ecosciences
is a Nevada corporation. Nevada law permits the indemnification of officers and directors against expenses incurred in successfully
defending against a claim. Nevada law also authorizes Nevada corporations to indemnify their officers and directors against expenses
and liabilities incurred because of their being or having been an officer or director. Our organizational documents provide for
this indemnification to the fullest extent permitted by law.
We
currently do not maintain any insurance coverage. In the event that we are found liable for damage or other losses, we would incur
substantial and protracted losses in paying any such claims or judgments. Although we intend to acquire such coverage immediately
upon resources becoming available, there is no guarantee that we can secure such coverage or that any insurance coverage would
protect us from any damages or loss claims filed against it.
Risks
Relating to Ownership of Our Common Stock
The
shares of Common Stock issued to the former Eco-Logical stockholders pursuant to the Merger Agreement are “restricted securities”
and, as such, may not be sold except in limited circumstances.
The
shares of Common Stock of On-Air Impact, Inc. issued to the former stockholders of Eco-Logical in exchange for their shares of
common stock of Eco-Logical pursuant to the Merger Agreement have not been registered under the Securities Act or any state securities
law. As a result, the shares will be “restricted securities” under the Securities Act and they may not be sold, transferred,
pledged or otherwise disposed of unless they are registered under the Securities Act and applicable state securities laws, except
in a transaction which, to our satisfaction and that of our counsel, is exempt from such registration requirements. We are not
currently required to register the resale of the shares of Common Stock to enable those shares to be freely tradable and even
if we were, we cannot assure you that the SEC will declare the registration statement effective, or that once declared effective,
that the SEC will not take action to suspend such effectiveness.
In
addition, Rule 144 promulgated under the Securities Act, which permits the resale of the shares of Common Stock, subject to various
terms and conditions, is not available until one year has elapsed since we filed our Super Form 8-K on May 15, 2014 containing
“Form 10 information” and only if we are current in meeting our SEC filing requirements. As a result, your ability
to sell your shares may be limited.
Because
we became public by means of a reverse merger, we may not be able to attract the attention of major brokerage firms.
There
may be risks associated with us becoming public through a “reverse merger.” Securities analysts of major brokerage
firms may not provide coverage of us since there is no incentive to brokerage firms to recommend the purchase of our common stock.
No assurance can be given that brokerage firms will, in the future, want to conduct any offerings on behalf of our post-merger
company.
A
decline in the price of our common stock could affect our ability to raise further working capital and adversely impact our operations.
Although
our common stock is quoted on the OTCPINK, we can have no assurances that a proper market will ever develop, and should a market
develop we will have no control over the market price of our common stock. Any market price is likely to be highly volatile. Factors,
including regulatory matters, concerns about our financial condition, operating results, litigation, government regulation, developments
or disputes relating to current or future agreements or title to our claims or the success of our new business model may have
a significant impact on the market price of our stock, causing the market price to decline. In addition, potential dilutive effects
of future sales of shares of common stock by stockholders and by us could also have an adverse effect on the price of our securities.
Such a decline would seriously hinder our ability to raise additional capital and prevent us from fully implementing our business
plan and operations.
In
addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated
to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market
price of our common stock.
There
is currently a very limited trading market for our common stock, and we cannot ensure that one will ever develop or be sustained.
To
date, there has been a very limited trading market for our common stock. We cannot predict how liquid the market for our common
stock might become. We anticipate having our common stock continue to be quoted for trading on the OTC Market, however, we cannot
be sure that such quotations will continue. We currently do not satisfy the initial listing standards of any national securities
exchange and cannot ensure that we will be able to satisfy such listing standards or that our common stock will be accepted for
listing on any such exchange in the future. Should we fail to satisfy the initial listing standards of such exchanges, or our
common stock is otherwise rejected for listing and remain listed on the OTC Market or suspended from the OTC Market, the trading
price of our common stock could suffer and the trading market for our common stock may be less liquid and our common stock price
may be subject to increased volatility. Furthermore, for companies whose securities are traded in the OTC Market, it is more difficult
(1) to obtain accurate quotations, (2) to obtain coverage for significant news events because major wire services generally do
not publish press releases about such companies and (3) to obtain needed capital.
As
a former shell company, resales of shares of our restricted common stock in reliance on Rule 144 of the Securities Act are subject
to the requirements of Rule 144(i).
Rule
144 under the Securities Act, which generally permits the resale, subject to various terms and conditions, of restricted securities
after they have been held for six months will not immediately apply to our common stock because we were at one time designated
as a “shell company” under SEC regulations. Pursuant to Rule 144(i), securities issued by a current or former shell
company that otherwise meet the holding period and other requirements of Rule 144 nevertheless cannot be sold in reliance on Rule
144 until one year after the date on which the issuer filed current “Form 10 information” (as defined in Rule 144(i))
with the SEC reflecting that it ceased being a shell company, and provided that at the time of a proposed sale pursuant to Rule
144, the issuer has satisfied certain reporting requirements under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”). The filing of our Current Report on Form 8-K dated May 15, 2014 started the running of such one-year period. Because,
as a former shell company, the reporting requirements of Rule 144(i) will apply regardless of holding period, restrictive legends
on certificates for shares of our common stock cannot be removed except in connection with an actual sale that is subject to an
effective registration statement under, or an applicable exemption from the registration requirements of, the Securities Act.
We
may, in the future, issue additional shares of our common stock and/or preferred stock, which would reduce investors’ percent
of ownership and may dilute our share value.
Our
Articles of Incorporation, as amended, authorizes the issuance of up to 1,950,000,000 shares of common stock and 50,000,000 shares
of preferred stock, of which 23,200,000 shares have been designated of the date of this Annual Report. The Articles of Incorporation
authorize our Board to prescribe the series and the voting powers, designations, preferences, limitations, restrictions and relative
rights of any undesignated shares of our preferred stock. The future issuance of common stock and preferred stock may result in
substantial dilution in the percentage of our common stock held by our then existing stockholders. We may value any common stock
or preferred stock issued in the future on an arbitrary basis. The issuance of common stock for financing, future services or
acquisitions or other corporate actions may have the effect of diluting the value of the shares held by our investors, and might
have an adverse effect on any trading market for our common stock.
Offers
or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.
If
our stockholders sell substantial amounts of their shares of our common stock, or shares of our common stock underlying any outstanding
securities held by them, in the public market under Rule 144 or upon registration of such shares pursuant to an effective registration
statement, or it could create a circumstance commonly referred to as an “overhang” and in anticipation of which the
market price of our common stock could fall. The existence of an overhang, whether or not sales have occurred or are occurring,
also could make more difficult our ability to raise additional financing through the sale of equity or equity-related securities
in the future at a time and price that we deem reasonable or appropriate.
Our
Articles of Incorporation and Bylaws provide for indemnification of our officers and directors.
Our
Articles of Incorporation provide for the indemnification of our officers and directors. We have been advised that, in the opinion
of the SEC, indemnification for liabilities arising under federal securities laws is against public policy as expressed in the
Securities Act and is, therefore, unenforceable.
We
do not expect to pay dividends in the foreseeable future.
We
currently do not intend to pay any cash dividends in the foreseeable future and we intend to retain future earnings, if any, to
finance the expansion of our business. Our future dividend policy will depend on the requirements of financing agreements to which
we may be a party and applicable law. Any future determination to pay dividends will be at the discretion of our Board and will
depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions
and applicable law.
There
can be no assurances that an active trading market may develop for our Common Stock, or if developed, be maintained.
The
average trading volume in our stock has been historically low, with little or no trading at all on some days. As a result, an
investor may find it difficult to dispose of, or to obtain accurate quotations of the price of, our Common Stock. Accordingly,
investors must assume they may have to bear the economic risk of an investment in our Common Stock for an indefinite period of
time. There can be no assurance that a more active market for the Common Stock will develop, or if one should develop, there is
no assurance that it will be maintained. This severely limits the liquidity of our Common Stock, and would likely have a material
adverse effect on the market price of our Common Stock and on our ability to raise additional capital.
Our
Common Stock is subject to the “penny stock” rules of the SEC and the trading market in the securities is limited,
which makes transactions in the stock cumbersome and may reduce the value of an investment in the stock.
The
SEC has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as
any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share,
subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require:
●
|
that
a broker or dealer approve a person’s account for transactions in penny stocks; and
|
|
|
●
|
the
broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity
of the penny stock to be purchased.
|
In
order to approve a person’s account for transactions in penny stocks, the broker or dealer must:
●
|
Obtain
financial information and investment experience objectives of the person; and
|
|
|
●
|
make
a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient
knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.
|
The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form sets forth:
●
|
the
basis on which the broker or dealer made the suitability determination; and
|
|
|
●
|
that
the broker or dealer received a signed, written agreement from the investor prior to the transaction.
|
Generally,
brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make
it more difficult for investors to dispose of common stock and cause a decline in the market value of stock.
Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the
rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to
be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny
stocks.
The
price of our Common Stock may become volatile, which could lead to losses by investors and costly securities litigation.
The
trading price of our Common Stock is likely to be highly volatile and could fluctuate in response to factors such as:
●
|
actual
or anticipated variations in our operating results;
|
|
|
●
|
announcements
of developments by us or our competitors;
|
|
|
●
|
announcements
by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
|
|
|
●
|
adoption
of new accounting standards affecting our Company’s industry;
|
|
|
●
|
additions
or departures of key personnel;
|
|
|
●
|
sales
of our Common Stock or other securities in the open market; and
|
|
|
●
|
other
events or factors, many of which are beyond our control.
|
The
stock market is subject to significant price and volume fluctuations. In the past, following periods of volatility in the market
price of a company’s securities, securities class action litigation has often been initiated against the company. Litigation
initiated against us, whether or not successful, could result in substantial costs and diversion of our management’s attention
and resources, which could harm our business and financial condition.
We
do not anticipate dividends to be paid on our Common Stock, and investors may lose the entire amount of their investment.
Cash
dividends have never been declared or paid on the Common Stock, and we do not anticipate such a declaration or payment for the
foreseeable future. We expect to use future earnings, if any, to fund business growth. Therefore, stockholders will not receive
any funds absent a sale of their shares. We cannot assure stockholders of a positive return on their investment when they sell
their shares, nor can we assure that stockholders will not lose the entire amount of their investment.
If
securities analysts do not initiate coverage or continue to cover our Common Stock or publish unfavorable research or reports
about our business, this may have a negative impact on the market price of our Common Stock.
The
trading market for the Common Stock will depend on the research and reports that securities analysts publish about our business
and the Company. We do not have any control over these analysts. There is no guarantee that securities analysts will cover the
Common Stock. If securities analysts do not cover the Common Stock, the lack of research coverage may adversely affect its market
price. If we are covered by securities analysts, and our stock is the subject of an unfavorable report, our stock price and trading
volume would likely decline. If one or more of these analysts ceases to cover the Company or fails to publish regular reports
on the Company, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.
The
outstanding Series B Non-Convertible Preferred Stock has 80% voting control and is owned by an affiliate, thereby giving it significant
ability to influence the election of our directors and the outcome of matters submitted to our stockholders.
Generally,
the outstanding shares of Series B Non-Convertible Preferred Stock shall vote together with the shares of Common Stock and other
voting securities of the Company as a single class and, regardless of the number of shares of Series B Non-Convertible Preferred
Stock outstanding and as long as at least one of such shares of Series B Non-Convertible Preferred Stock is outstanding, shall
represent eighty percent (80%) of all votes entitled to be voted at any annual or special meeting of stockholders of the Company
or action by written consent of stockholders. Each outstanding share of the Series B Non-Convertible Preferred Stock shall represent
its proportionate share of the 80% which is allocated to the outstanding shares of Series B Non-Convertible Preferred Stock. Joel
Falitz, the Company’s CEO and sole director owns 100% of the 200,000 issued and outstanding shares of Series B Non-Convertible
Preferred Stock. As a result, Mr, Falitz has the ability to significantly influence the outcome of issues submitted to our stockholders.
The interests of this stockholder may not always coincide with our interests or the interests of other stockholders, and this
stockholder may act in a manner that advances his best interests and not necessarily those of our other stockholders. As a consequence,
it may be difficult for investors to remove our management. The ownership of this stockholder could also deter unsolicited takeovers,
including transactions in which stockholders might otherwise receive a premium for their shares over then current market prices.
Material
weaknesses in our internal control over financial reporting may adversely affect our Common Stock.
We
are subject to the reporting requirements of the Exchange Act, and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”).
The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition,
proxy statement, and other information. The Sarbanes-Oxley Act requires, among other things, that we establish and maintain effective
disclosure controls and procedures and internal controls and procedures for financial reporting. Section 404 of the Sarbanes-Oxley
Act requires that we include a report of management on our internal control over financial reporting in our annual report on Form
10-K. That report must contain an assessment by management of the effectiveness of our internal control over financial reporting
and must include disclosure of any material weaknesses in internal control over financial reporting that we have identified. Effective
internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial
reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment
existed, and our business and reputation with investors may be harmed. As a result, our small size and any current internal control
deficiencies may adversely affect our financial condition, results of operation and access to capital. We have not performed an
in-depth analysis to determine if historical un-discovered failures of internal controls exist, and may in the future discover
areas of our internal control that need improvement. Any inability to report and file our financial results accurately and timely
could harm our reputation and adversely impact the trading price of our Common Stock.
The
Financial Industry Regulatory Authority (FINRA) sales practice requirements may also limit a stockholder’s ability to buy
and sell our Common Stock.
In
addition to the “penny stock” rules described above, the Financial Industry Regulatory Authority, which we refer to
as FINRA, has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable
grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities
to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s
financial status, tax status, investment objectives and other information. Under interpretations of these rules, the FINRA believes
that there is a high probability that speculative low priced securities will not be suitable for at least some customers. The
FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our Common Stock, which may
limit your ability to buy and sell our Common Stock and have an adverse effect on the market for shares of our Common Stock.